NCT03147677View on ClinicalTrials.gov

Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 28, 2016

Primary Completion Date

July 30, 2018

Study Completion Date

December 30, 2018

Conditions
Type 2 Diabetic Nephropathy
Interventions
DRUG

Alfacalcidol

DRUG

Irbesartan

Trial Locations (3)

410000

The Third Xiangya Hospital of Central South University, Changsha

413000

Hunan Yiyang Central Hospital, Yiyang

423000

Hunan Chenzhou NO.1 People's Hospital, Chenzhou

All Listed Sponsors
lead

The Third Xiangya Hospital of Central South University

OTHER

NCT03147677 - Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan | Biotech Hunter | Biotech Hunter